Press Releases

February 12, 2019 in Press Release

NeuroPace Announces New Category I CPT Code from AMA for Electrocorticography from an Implanted Brain Neurostimulator

Supports Value of Insights Provided by Brain Recordings from the NeuroPace RNS® System for Drug-Resistant Epilepsy MOUNTAIN VIEW, Calif. — February 12, 2019 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT®)... Read More
December 2, 2018 in Press Release

NeuroPace Announces Final Results from the Largest Prospective Clinical Study in the Field of Neuromodulation with 9-Year Follow-Up at the 2018 American Epilepsy Society Annual Meeting

More than One-Third of Drug-Resistant Epilepsy Patients Achieved ≥90% Seizure Reduction with the RNS System. NEW ORLEANS--(BUSINESS WIRE)--American Epilepsy Society Annual Meeting, Booth 519 — NeuroPace, Inc., a Silicon Valley-based medical technology company that recently launched the Next-Gen RNS® System for refractory epilepsy, today announced complete results from its groundbreaking... Read More
June 1, 2018 in Press Release

NeuroPace Launches Next Generation RNS System, the World’s Only Brain-Computer Interface for the Treatment of Refractory Epilepsy

Next Gen RNS System provides unprecedented brain data with long-lasting, 8-year battery life. MOUNTAIN VIEW, Calif -- June 1, 2018 – NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced the launch of its Next Gen RNS® System for the treatment of refractory epilepsy, which affects an estimated 1... Read More
December 5, 2017 in Press Release

NeuroPace Unveils 8-Year Prospective Clinical Outcomes and Groundbreaking Research Using Deep Learning Algorithms to Identify Seizure Biomarkers

WASHINGTON–(EON: Enhanced Online News)–American Epilepsy Society Annual Meeting, Booth 1101–NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive neurostimulation system for epilepsy, today announces 5 poster presentations, including new 8-year prospective clinical trial data presented at the American Epilepsy Society’s (AES) Annual…

Read More
October 23, 2017 in Press Release, Uncategorized

NeuroPace Closes $74 Million Equity Funding to Accelerate Patient Access to the World’s First Brain-Responsive Neurostimulation System to Treat Epilepsy

MOUNTAIN VIEW, Calif. – October 24, 2017 – NeuroPace, Inc., a Silicon Valley-based medical technology company that developed the world’s first and only closed-loop brain-responsive neurostimulation system shown to significantly reduce seizure frequency, announced today that it closed a $74 million round of funding led by the KCK Group and…

Read More